Literature DB >> 2242393

Polymers for biodegradable medical devices. V. Hydroxybutyrate-hydroxyvalerate copolymers: effects of polymer processing on hydrolytic degradation.

M Yasin1, S J Holland, B J Tighe.   

Abstract

The effects of melt processing on those properties of polyhydroxybutyrate-hydroxyvalerate copolymers that control hydrolytic stability were studied. Initial experiments using a non-thermal preparation technique enabled the relationship between initial molecular weight and rate of hydrolytic degradation to be established. This rate was conveniently expressed in terms of the time for 10% by weight of the sample to be eroded. By varying melt processing conditions, the range of effects of processing on sample molecular weight and molecular weight distribution were investigated. These effects were found to be quite dramatic, with a reduction to 50% of the initial molecular weight being readily achieved. Temperature, shear rate and dwell time interrelated to control the extent of thermal degradation achieved during processing. The principal effect of copolymer composition resulted from the fact that an increase in hydroxyvalerate content led to a reduction in melting point and enabled milder processing conditions to be used. Enhanced crystallinity, resulting from more favourable processing conditions reduced hydrolytic degradation rates. As a result, melt processing produced a complex interrelation of effects, all of which influenced the hydrolytic stability of the fabricated specimen. In general, molecular weight effects predominated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242393     DOI: 10.1016/0142-9612(90)90057-w

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  1 in total

1.  Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) based tissue engineering matrices.

Authors:  Gamze Torun Köse; Suzan Ber; Feza Korkusuz; Vasif Hasirci
Journal:  J Mater Sci Mater Med       Date:  2003-02       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.